INFI - Infinity Pharmaceuticals EPS misses by $0.03 misses on revenue July, 30 2019 07:34 AM Infinity Pharmaceuticals Inc. Infinity Pharmaceuticals (NASDAQ:INFI): Q2 GAAP EPS of -$0.18 misses by $0.03.More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...